Arecor Therapeutics plc

Equities

AREC

GB00BMWLM973

Market Closed - London S.E. Other stock markets 16:35:23 18/06/2025 BST			5-day change	1st Jan Change
43.50 ^GBX	0.00%		0.00%	-40.82%

06-02	Arecor Therapeutics plc Announces Alan Smith to Retire from its Board, Effective 2 June 2025	CI
05-26	Arecor Therapeutics plc - Special Call

Arecor Therapeutics plc, 2023 Earnings Call, May 16, 2024

Published on 16/05/2024 at 11:00

Presenter Speech
Sarah Howell (Executives)

Okay. So good morning, everybody. And it's a pleasure to be here. Thank you for taking the time. We've got a full room today, which is great. So welcome,

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about Arecor Therapeutics plc

Arecor Therapeutics plc Announces Alan Smith to Retire from its Board, Effective 2 June 2025	06-02	CI
Arecor Therapeutics plc - Special Call	05-26
Arecor shares climb 18% on collaboration with Skye Bioscience	05-19	AN
Arecor Partners with Skye Bioscience to Enhance Obesity Drug Formulation	05-19	MT
Skye Bioscience, Inc. Establishes Partnership with Arecor Therapeutics to Develop Enhanced Formulation of Obesity Candidate Nimacimab	05-19	CI
Arecor Sells Non-Ogluo Tetris Pharma Product Rights to Aspire Pharma	05-08	MT
Arecor Therapeutics Sells Rights To Non-Ogluo Products	05-08	RE
Arecor Therapeutics plc Auditor Raises 'Going Concern' Doubt	05-05	CI
Arecor Therapeutics plc, 2024 Earnings Call, May 01, 2025	05-01
Arecor Therapeutics plc, 2024 Earnings Call, Apr 22, 2025	04-22
Arecor Therapeutics sees "significant future growth" as revenue rises	04-22	AN
Earnings Flash (AREC.L) Arecor Therapeutics Reports FY24 Revenue GBP5.1M	04-22	MT
Earnings Flash (AREC.L) Arecor Therapeutics Posts FY24 Loss GBP-0.31	04-22	MT
Arecor Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2024	04-22	CI
Arecor Therapeutics Enters Collaboration With Pharmaceutical Partner	03-26	RE
Arecor Therapeutics plc Enters Collaboration with Major Global Pharmaceutical Partner	03-26	CI
Arecor Therapeutics strikes deal for development of peptide therapy	03-12	AN
Arecor Therapeutics Enters Partnership to Develop Peptide Therapy Formulations	03-12	MT
Arecor Therapeutics Partners With Biopharma Firm For Novel Peptide Therapy	03-12	RE
Arecor Therapeutics plc Announces Formulation Development Collaboration with Biopharmaceutical Company to Develop Novel Formulation of Peptide Therapeutics	03-12	CI
Arecor Therapeutics confident for the future as revenue rises	02-03	AN
Arecor Therapeutics Says Non-Clinical PK Data For Oral GLP-1 On Track To Be Delivered In H1'25	02-03	RE
Arecor Therapeutics shares tumble as plans Tetris wind-down	01-10	AN
Arecor Therapeutics to Shutter Tetris Pharma Unit; Ends License Deal with Xeris	01-10	MT
Arecor Therapeutics plc - Shareholder/Analyst Call	01-10